Refine Biology completes Series B Financing

Recently, it was reported that Beijing Refine Biology Co., Ltd. (Refine Biology) has completed USD15.48 million Series B Financing, with Shenzhen Cowin Asset Management Co., Ltd. (Cowin Capital) as the lead investor, followed by Toutoushidao Investme...

Sweeteners China News 202110

www.cnchemicals.com